Pseudo-Generic Products and Barriers to Entry in Pharmaceutical Markets
Author
Abstract
Suggested Citation
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Giovanni B. Ramello, 2008.
"Semiotica, diritti e mercato. Economia del marchio nel terzo millennio,"
ECONOMIA E POLITICA INDUSTRIALE, FrancoAngeli Editore, vol. 2008(1), pages 107-125.
- Ramello, Giovanni B., 2008. "Semiotica, diritto e mercato. Economia del marchio nel terzo millenio," POLIS Working Papers 102, Institute of Public Policy and Public Choice - POLIS.
- Paul Grootendorst, 2007. "Effects of 'Authorized-Generics' on Canadian Drug Prices," Social and Economic Dimensions of an Aging Population Research Papers 201, McMaster University.
- Regan, Tracy L., 2008.
"Generic entry, price competition, and market segmentation in the prescription drug market,"
International Journal of Industrial Organization, Elsevier, vol. 26(4), pages 930-948, July.
- Tracy L. Regan, 2007. "Generic entry, price competition, and market segmentation in the prescription drug market," Working Papers 2010-7, University of Miami, Department of Economics.
- Laurent Granier & S颡stien Trinquard, 2012.
"Predation in off-patent drug markets,"
Applied Economics, Taylor & Francis Journals, vol. 44(17), pages 2171-2186, June.
- Laurent Granier & Sébastien Trinquart, 2010. "Predation in Off-Patent Drug Markets," Working Papers 1027, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
- Laurent Granier & Sébastien Trinquard, 2012. "Predation in Off-Patent Drug Markets," Post-Print halshs-00537018, HAL.
- Marjit, Sugata & Kabiraj, Tarun & Dutta, Arijita, 2009. "Strategic Under-utilization of Patents and Entry Deterrence: The Case of Pharmaceutical Industry," MPRA Paper 19157, University Library of Munich, Germany.
- Aidan Hollis, 2005. "How do Brands’ “Own Generics” Affect Pharmaceutical Prices?," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 27(4), pages 329-350, December.
- Brekke, Kurt R. & Canta, Chiara & Straume, Odd Rune, 2016.
"Reference pricing with endogenous generic entry,"
Journal of Health Economics, Elsevier, vol. 50(C), pages 312-329.
- Brekke, Kurt R. & Canta, Chiara & Straume, Odd Rune, 2015. "Reference pricing with endogenous generic entry," Discussion Paper Series in Economics 4/2015, Norwegian School of Economics, Department of Economics.
- Kurt R. Brekke & Chiara Canta & Odd Rune Straume, 2015. "Reference pricing with endogenous generic entry," NIPE Working Papers 2/2015, NIPE - Universidade do Minho.
- Giovanni B. Ramello, 2006.
"What'S In A Sign ? Trademark Law And Economic Theory,"
Journal of Economic Surveys, Wiley Blackwell, vol. 20(4), pages 547-565, September.
- Ramello, Giovanni, 2006. "What's in a sign? Trademark law and enconomic theory," POLIS Working Papers 67, Institute of Public Policy and Public Choice - POLIS.
- David Reiffen & Michael R. Ward, 2007.
"'Branded Generics' as a strategy to limit cannibalization of pharmaceutical markets,"
Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 251-265.
- Michael R. Ward & David Reiffen, 2005. "“Branded Generics” As A Strategy To Limit Cannibalization Of Pharmaceutical Markets," Working Papers 0502, University of Texas at Arlington, Department of Economics.
- de Vries, A.G.B. & Pennings, H.P.G. & Block, J.H., 2013. "Trademark or patent? The effects of market structure, customer type and venture capital financing on start-ups' IP decisions," ERIM Report Series Research in Management ERS-2013-002-STR, Erasmus Research Institute of Management (ERIM), ERIM is the joint research institute of the Rotterdam School of Management, Erasmus University and the Erasmus School of Economics (ESE) at Erasmus University Rotterdam.
- Vasco Rodrigues & Ricardo Gonçalves & Hélder Vasconcelos, 2014. "Anti-Competitive Impact of Pseudo-Generics," Journal of Industry, Competition and Trade, Springer, vol. 14(1), pages 83-98, March.
- Farasat A. S. Bokhari & Franco Mariuzzo & Arnold Polanski, 2020.
"Entry limiting agreements: First‐mover advantage, authorized generics, and pay‐for‐delay deals,"
Journal of Economics & Management Strategy, Wiley Blackwell, vol. 29(3), pages 516-542, July.
- Farasat A.S. Bokhari & Franco Mariuzzo & Arnold Polanski, 2020. "Entry limiting agreements: First mover advantage, authorized generics and pay-for-delay deals," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2015-05v4, Centre for Competition Policy, University of East Anglia, Norwich, UK..
- Ying Kong & James Seldon, 2006. "Pseudo-Generic Products and Barriers to Entry in Pharmaceutical Markets: Reply," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 28(2), pages 189-193, March.
- Yunyun Wan, 2018. "Brand Loyalty and Generic Entry: Why Do Brand-Name Drug Companies Launch Their Own Generics?," The Japanese Economic Review, Springer, vol. 69(3), pages 340-346, September.
- Ying Kong, 2009. "Competition between brand‐name and generics – analysis on pricing of brand‐name pharmaceutical," Health Economics, John Wiley & Sons, Ltd., vol. 18(5), pages 591-606, May.
- Ricardo Gonçalves & Vasco Rodrigues & Hélder Vasconcelos, 2015. "Reference pricing in the presence of pseudo-generics," International Journal of Health Economics and Management, Springer, vol. 15(3), pages 281-305, September.
- Laurent Granier & Sébastien Trinquard, 2011. "Predation in Off-Patent Drug Markets," Post-Print hal-00687806, HAL.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:kap:revind:v:25:y:2004:i:1:p:71-86. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.